The BT Test^®, is not a genetic test. It detects key blood-based biomarkers that are associated with early breast cancer development. Using a proprietary analytical relational algorithm, the test has demonstrated the ability to detect the actual presence of breast cancer with a high level of accuracy.

LC Sentinel™ is a novel blood test for the detection of lung cancer in current, former and families of smokers. LC Sentitel™ is being developed used as a screening tool for these high risk populations.

OvDx™ is a non-invasive blood test for ovarian cancer detection. No current molecular diagnostics exist for the screening and detection of ovarian cancer whis is diagnosed in 22,000 new women every year in the United States.